Management of coronary artery disease: therapeutic options in patients with diabetes

T Hammoud, JF Tanguay, MG Bourassa - Journal of the American College …, 2000 - jacc.org
OBJECTIVES The aim of this review is to discuss the particularities of coronary artery
disease (CAD), the effect of intensive medical management and the outcome of …

Is insulin an antiinflammatory molecule?

UN Das - Nutrition, 2001 - Elsevier
I suggest that insulin suppresses the secretion and antagonizes the harmful effects of tumor
necrosis factor-α, macrophage migration-inhibitory factor, and superoxide anion. Therefore …

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term …

K Malmberg, A Norhammar, H Wedel, L Rydén - Circulation, 1999 - ahajournals.org
Background—The Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction
(DIGAMI) study addressed prognostic factors and the effects of concomitant treatment and …

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

BR Chaitman, SL Skettino, JO Parker, P Hanley… - Journal of the American …, 2004 - jacc.org
Objectives: The primary objective of the Monotherapy Assessment of Ranolazine In Stable
Angina (MARISA) trial was to determine the dose-response relationship of ranolazine, a …

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

L Timmers, JPS Henriques, DPV de Kleijn… - Journal of the American …, 2009 - jacc.org
Objectives: This study sought to examine whether exenatide is capable of reducing
myocardial infarct size. Background: Exenatide is a glucagon-like peptide (GLP)-1 analogue …

Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled …

HP Selker, JR Beshansky, PR Sheehan, JM Massaro… - Jama, 2012 - jamanetwork.com
Context Laboratory studies suggest that in the setting of cardiac ischemia, immediate
intravenous glucose-insulin-potassium (GIK) reduces ischemia-related arrhythmias and …

High levels of fatty acids delay the recoveryof intracellular pH and cardiac efficiency inpost-ischemic hearts by inhibiting glucose oxidation

Q Liu, JC Docherty, JCT Rendell, AS Clanachan… - Journal of the American …, 2002 - jacc.org
Objectives: This study was designed to determine if the fatty acid-induced increase in H+
production from glycolysis uncoupled from glucose oxidation delays the recovery of …

Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials

AG Pittas, RD Siegel, J Lau - Archives of internal medicine, 2004 - jamanetwork.com
Background Hyperglycemia is common in critically ill hospitalized patients, and it is
associated with adverse outcomes, including increased mortality. The objective of this meta …

Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial

L Ceremużyński, A Budaj, A Czepiel… - … drugs and therapy, 1999 - Springer
We aimed to assess the clinical efficacy of glucose-insulin-potassium (GIK) in acute
myocardial infarction. Experimental data provided evidence of the beneficial effects of GIK …

Glycogen synthase kinase 3β as a target for the therapy of shock and inflammation

L Dugo, M Collin, C Thiemermann - Shock, 2007 - journals.lww.com
After the discovery that glycogen synthase kinase (GSK) 3β plays a fundamental role in the
regulation of the activity of nuclear factor κB, a number of studies have investigated the …